Details of the Drug Formulations

General Information of Drug (ID: DMW4M97)

Drug Name
Clevidipine butyrate Drug Info
Synonyms
Clevidipine; Cleviprex; 167221-71-8; Clevelox; rac-Clevidipine; H 324/38; Methyl (1-oxobutoxy)methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dime thyl-3,5-pyridinedicarboxylate; Methyl (1-oxobutoxy)methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate; Cleviprex (TN); 3-((butyryloxy)methyl) 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate; METHYL 5-{[(BUTANOYLOXY)METHOXY]CARBONYL}-4-(2,3-DICHLOROPHENYL)-2,6-DIMETHYL-1,4-DIHYDROPYRIDINE-3
Indication
Disease Entry ICD 11 Status REF
Hypertension BA00-BA04 Approved [1]
Cross-matching ID
PubChem CID
153994
ChEBI ID
CHEBI:135738
CAS Number
167221-71-8
TTD ID
D09ELP
INTEDE ID
DR0339
ACDINA ID
D00953

Full List of Drug Formulations Containing This Drug

Clevidipine 25mg/50ml Emulsion
Company Formulation ID FDA Description
Chiesi F24184 Soybean Oil; Glycerin; Purified Egg Yolk Phospholipids; Oleic Acid; Disodium Edetate
------------------------------------------------------------------------------------
Clevidipine 50mg/100ml Emulsion
Company Formulation ID FDA Description
Chiesi F24185 Soybean Oil; Glycerin; Purified Egg Yolk Phospholipids; Oleic Acid; Disodium Edetate
------------------------------------------------------------------------------------
Clevidipine 125mg/250ml Emulsion
Company Formulation ID FDA Description
Chiesi F24186 Soybean Oil; Glycerin; Purified Egg Yolk Phospholipids; Oleic Acid; Disodium Edetate
------------------------------------------------------------------------------------

References

1 2008 FDA drug approvals. Nat Rev Drug Discov. 2009 Feb;8(2):93-6.